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In this thesis (TFG) the results of the comparison between different methods to obtain a 
recombinant protein, by orthologous and heterologous expression, are exposed. This study will 
help us to identify the best way to express and purify a recombinant protein that will be used for 
biotechnology applications.  
In the first part of the project the goal was to find the best expression and purification system to 
obtain the recombinant protein of interest. To achieve this objective, a system expression in 
bacteria and in yeast was designed. The DNA was cloned into two different expression vectors 
to create a fusion protein with two different tags, and the expression of the protein was induced 
by IPTG or glucose. Additionally, in yeast, two promoters where used to express the protein, the 
one corresponding to the same protein (orthologous expression), and the ENO2 promoter 
(heterologous expression). The protein of interest is a NAD-dependent enzyme so, in a second 
time, its specific activity was evaluated by coenzyme conversion.  
The results of the TFG suggest that, comparing the model organisms, bacteria are more efficient 
than yeast because the quantity of protein obtained is higher and better purified. Regarding 
yeast, comparing the two expression mechanisms that were designed, heterologous expression 
works much better than the orthologous expression, so in case that we want to use yeast as 
expression model for the protein of interest, ENO2 will be the best option. Finally, the 
enzymatic assays, done to compare the effectiveness of the different expression mechanisms 
respect to the protein activity, revealed that the protein purified in yeast had more activity in 
converting the NAD coenzyme. 
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2- Introduction 
 
Protein biotechnology is involved in the isolation, production and improvement of biological 
properties from specific proteins obtained from natural sources like plants, animals or 
microorganisms for subsequent use in various applications. Recombinant DNA technology has 
played an important role in the development of protein biotechnology. 
1
 
A recombinant protein, or heterologous protein, is one whose synthesis is performed in another 
organism distinct from the native one. 
2
 
 
Nowadays, multiple systems to obtain recombinant proteins for biotechnology applications have 
been developed.
3
 Their production is made in expression systems commercially available or in 
designed ones according to specific needs. An expression system is formed by a host organism 
and an expression vector or DNA fragments that contain genetic elements necessaries for the 
transcription and translation in this organism, and also receive the recombinant DNA molecules.  
 
For selecting a suitable expression system for the synthesis of a recombinant protein, there are 
some considerations that we have to take into account: biological origin, chemical and 
biological properties from the protein of interest, subsequent application and bioprocesses that 
will be used for his production.   
 
A variety of hosts that are currently used, ranging from unicellular organism such as bacteria, 
fungus or, yeast,  and mammals cell lines, insects or plants, till complete organisms like animals 
or transgenic plants.  
 
Among of the prokaryotes we can find bacteria, of which Escherichia coli (E.coli) has been the 
most used, although Bacillus subtilis, Caulobacter crescentus, Pseudomonas sp, Lactobacillus 
lactis, etc, have been used also.  
However, expression systems of recombinant proteins based in yeast, which is an eukaryote, 
have proved to be an efficient and economical source of proteins of industrial interest. In yeast 
group, Saccharomyces cerevisiae (S.cerevisiae)
4
 has been used for many years as a mechanism 
for the expression of heterologous genes but, nowadays, new organisms are also used, like 
Pichia pastoris, Schizosaccharomyces pombe and Hansenula polymorpha. 
5
 
 
In this project, the main objective is to develop a stable protein overexpression method, above 
all in yeast, but to start in the first steps of this project we started investigating the effectiveness 
of that expression in two model organisms previously mentioned: Escherichia coli 
6
 and 
Saccharomyces cerevisiae.
7
 
 5  
 
Proteins that are going to be overexpressed will be called BC1 and BC2 because, for 
confidentiality reasons we can’t mention the real names.  
 
Expression system in E.coli  
Using E.coli as a model organism, the expression system that we used consist in cloning and 
expressing the BC1 and BC2 genes through plasmids and inducing them by Isopropyl β-D-1-
thiogalactopyranoside (IPTG) who triggers transcription of the lac operon and induce then the 
protein expression that is under his control. 
8
 
We designed two different methods of fusion proteins for the heterologous protein expression. 
We fuse the gene of interest to a histidine tag and to a glutathione S-transferase (GST) tag 
provided by the vectors in which the gene was cloned, pET28a and pGEX-4T-3 respectively.
9
 
These tags can give us advantages and disadvantages in the purification step because the poly-
histidine tag can be attached into a divalent metal matrix and be eluted by imidazole 
competition, but the tag or the imidazole can affect the protein properties. On the other hand, 
GST can be attached to a glutathione agarose and be eluted by glutathione, but the dimerization 
of the GST and the elution with glutathione can affect the protein properties also. Some tags can 
protect the proteins against intracellular proteases or help to its solubilisation.
3 
 
E.coli is the most used expression system for the expression of heterologous proteins due to its 
high growth rate, its capacity for continuous cultivation and low cost. As it is well studied, we 
have a lot of knowledge about its genetics, physiognomy and genome sequence, that’s why 
many expression systems were designed in this model, for different applications and 
compatibilities. 
2, 3  
 
Nevertheless, E.coli has some limitations, for example: 
- Impossibility of post-transcriptional modifications that are necessaries for the correct 
conformation of the structure.  
- Absence of appropriate chaperones for some proteins, which causes an incorrect 
folding.  
- Codons preferences, which can degenerate the genetic code, so the translation and the 
expression yield decreases considerably.  
- High proteases content that can affect the final product, impeding the expression of 
active proteins; that’s why some strains, like BL21, are used, because are deficient in 
some proteases.     
- Generate endotoxins that are unhealthy.  
- Inefficiency to secrete proteins into the culture medium and tendency to precipitate as 
insoluble inclusion bodies in the cytoplasm. 
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Another disadvantage that we had in our project is that we express a eukaryotic gene in a 
prokaryotic organism.   
 
Expression system in S. cerevisiae 
Using yeast as a model organism, the expression system was done without using plasmids, but 
tagging the gene of interest directly in the genome.  
In the yeast expression, a particular protein or enzyme may be of interest as a product itself (e.g. 
human alpha interferon), or may be of interest because it facilitates production by the host yeast 
of a desired metabolite (e.g. ethanol) or production of a food or beverage product (e.g. beer, 
wine, bread or spirits). To obtain high levels of expression, promoters are used because they 
increases the transcription, translation or mRNA stability of the gene if they are under 
appropriate growth conditions (e.g., if the promoter is inducible, in the presence of the inducing 
substance). 
10,11
 
In this project, two different promoters are used for the expression of the protein; one promoter 
corresponds to the specific one of the protein we want to express and the other corresponds to 
the ENO2 promoter, giving, in this way, an orthologous and heterologous expression 
respectively.  
ENO2 promoter of S. cerevisiae have the advantage of being regulated: expression can be 
repressed 20-fold by growing the yeast on a non-fermentable carbon source, such as glycerol, 
lactate or ethanol, but the expression of the desired gene can be induced by addition of glucose 
to the growth medium. 
12,13
 
 
S. cerevisiae is economic and meets all biosafety regulations for human applications, is 
considered a GRAS (Generally Recognized as Safe) organism by the american FDA and the 
european EFSA. By sharing many molecular, genetic and biochemical characteristics with 
higher organisms, has been confirmed the commercial potential of yeast expression systems. 
Yeast can produce correctly folded and soluble recombinant proteins that have undergone all the 
essential post-translational modifications to be functional, which is an advantage in the 
production of eukaryotic proteins. Moreover, yeast is easy to handle and has rapid growth. In 
addition, S. cerevisiae is one of the best characterized eukaryotic organisms and its genome has 
been fully sequenced. 
2, 3
 
 
The disadvantages of this organism are: production of hyperglycosylations and low efficiency in 
heterologous protein secretion. In addition, limitations appear when we compare it with the non-
conventional yeasts, which exhibit better yield as producers of certain heterologous proteins and 
are used in various processes developed on an industrial scale.  
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3- Objectives 
In this project, two main objectives were considered: 
1. Identify which is, between bacteria (E.coli) and yeast (S. cerevisiae), the best expression 
system to purify the recombinant protein object of this study. 
 
a. Compare the efficiency of the purification between 6*His-tag and GST-tag 
systems in E. coli. 
b. Compare the efficiency of the purification between bacterial model systems 
(using expression vectors) and yeast model system (protein tagged in the 
genome). 
c. Compare the efficiency rate between the production of orthologous and 
heterologous protein. 
d. Assay the enzymatic activity of the purified proteins. 
e. Compare the activity of the purified protein from E. coli and S. cerevisiae. 
 
2. Develop a stable overexpression method in yeast that allows us to obtain a considerably 
amount of purified protein with a high productivity. 
 
a. Compare the expression efficiency of the promoter of the own protein of 
interest with the efficiency of ENO2 promoter. 
b. Increase glucose concentration of the yeast culture to improve the efficiency of 
ENO2 promoter. 
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4- Materials and methods 
 
Materials  
The reagents for polymerase chain reaction (PCR) and KOD Hot Start DNA polymerase were 
purchased from Novagen. Page Ruler Prestained Protein Ladder, GeneRuler 1kb DNA ladder 
and plasmid isolation kit named GeneJET Plasmid Miniprep Kit were from Thermo Scientific. 
DNA and protein gel electrophoresis was performed using Bio-Rad tanks. SYBR safe DNA gel 
stain and Nickel-nitrilotriacetic acid (Ni-NTA) superflow were from Invitrogen. Restriction 
enzymes were purchased from New England Biolabs. Illustra GFX PCR DNA and Gel Band 
Purification Kit was from GE Healthcare. Rapid DNA Ligation Kit was obtained from Roche. 
DFS-Taq DNA Polymerase was purchased from Bioron. Oligonucleotide primers, monoclonal 
anti-PolyHistidine and β-Nicotinamide adenine dinucleotide hydrate (NAD) were ordered from 
Sigma-Aldrich. HRP-conjugated anti-mouse antibody was bought from Thermo Scientific. 
Luminata™ HRP Chemiluminescence Detection Reagents were purchased from Millipore and 
Amersham ECL Prime Western Blotting Detection Reagent was from GE Healthcare. Salmon 
sperm DNA solution was from Life Technologies.  
  
Strains and culture conditions 
E. coli DH5-α cells were used as hosts for plasmid transformation and isolation, and E. coli 
BL21 were used as hosts for protein expression and purification. E. coli strains were grown at 
37ºC in Luria-Bertani (LB) medium supplemented with ampicillin (100µg mL
-1
) for pGEX-4T-
3 and pFA6-KanMX6 vectors and with kanamycin (100µg mL
-1
) for pET28a vector.  
 
- Escherichia coli  
DH5-α and BL21 cell lines 
The DH5-α strain of E.coli is not pathogenic, and was used because it has multiple mutations 
that allow a high efficiency of transformation. Important mutations it contains are: endA1, 
allowing the degradation of endonuclease which ensures a higher speed of plasmid transfer and 
recA1, reducing homologous recombination leading to a greater stability of the insert. This 
strain already contains plasmids, and has the ability to accept the insertion of other plasmids 
exceptionally well. 
14
 
BL21 cell strains are convenient for transformation and protein expression. Upon addition of 
isopropyl-β-D-thiogalactopyranoside (IPTG), T7 RNA polymerase is expressed and it induces a 
high-level protein expression from T7 promoter driven expression vectors, like pET vector. E. 
coli BL21 (DE3) strain lacks both the lon protease and the ompT membrane protease, which 
may degrade expressed proteins. 
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- Saccharomyces cerevisiae 
Saccharomyces cerevisiae was grown in Yeast extract Peptone Dextrose (YPD) broth medium 
at 30ºC. The wild type strain used was BY4741 which genotype is: MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0. When yeast cells were transformed with DNA fragments containing 
kanamycin resistance cassette, YPD-G418 antibiotic plates were used for positive colonies 
selection. 
15
 
 
Plasmids 
Expression vectors pET28a were provided by Novagen, pGEX-4T-3 from GE Healthcare and 
pFA6-KanMX6 was purchased from Addgene. The pET28a-BC1 and the DNA of BC2 were 
from our laboratory stock. 
 
- pET28a vector 
 
Contain: bacterial expression vector with T7lac 
promoter, adds N-terminal His tag, thrombin 
cleavage site, internal T7 epitope tag, C-terminal His 
tag; kanamycin resistance gene and multiple cloning 
site (MSC) for restriction enzyme cloning. Size: 
5369bp.  
 
 
- pGEX-4T-3 vector 
 
Contain: Bacterial expression vector with Tac 
promoter, GST tag, thrombin cleavage site; ampicillin 
resistance and multiple cloning site (MSC) for 
restriction enzyme cloning. Size: 4968bp.  
 
 
 
 
- pFA6-KanMX6 
 
Contain: Yeast genomic targeting, ampicillin 
resistance, kanamycin resistant for yeast; multiple 
cloning site (MSC) for restriction enzyme cloning. 
5’sequencing primer: Sp6_primer and 3’ sequencing 
primer: T7_promoter. Size: 3938bp.  
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- Isolation of  plasmid DNA by miniprep  
 
To isolate plasmid DNA we used the GeneJET Plasmid Miniprep Kit, which consists in 
centrifuging the cells, resuspending them in resuspension buffer and using SDS/alkaline lysis to 
liberate the plasmid DNA. The resulting lysate was neutralized to create appropriate conditions 
for the binding of the plasmid DNA to the silica membrane in the spin column. Cell debris and 
SDS precipitate were pelleted by centrifugation, and the supernatant containing the plasmid 
DNA was loaded onto the spin column membrane. The absorbed DNA was washed to remove 
contaminants, and was then eluted with small volume of elution buffer (10mM Tris-HCl, pH 
8.5). After the purification of the plasmid, the concentration was measured using Nanodrop. 
 
- Cloning of BC2 DNA into expression vectors   
 
To clone the BC2 DNA into pET28a vector, we used PCR with BC2 in the plasmid BG1805 as 
a template and specific oligonucleotide primers were designed containing in the forward an 
EcoRI restriction site and in the reverse an XhoI restriction site. The amplification of the DNA 
was made by PCR using a KOD Polymerase with an annealing temperature of 60ºC for 10s 
during 35 cycles. (Not a single oligonucleotide will be shown for confidential motifs). 
16
 
The BC2 DNA fragment, obtained with the PCR, and the vectors were digested with restriction 
enzymes EcoRI and XhoI to create sticky ends in the DNA fragments and to open the 
expression vectors for the subsequent cloning, respectively. The BC2 DNA was ligated into the 
vectors using the Rapid DNA Ligation Kit to give pET28a-BC2 and pGEX-BC2.
17
 
The ligations mixtures were then transformed into DH5-α by heat shock and plated on LB+Kan 
for pET28a and pFa6-KanMX6 and LB+Amp for pGEX-4T-3. The colonies obtained were 
checked by colony PCR and, from the positives ones, the plasmid DNA was extracted with the 
miniprep kit.  
 
To clone His-BC2 into pFA6-KanMX6 vector, we amplified His-BC2 from pET28a-BC2 using 
specific oligonucleotide primers. SalI and BglII sites were incorporated into the forward and 
reverse primers, respectively, to clone into the expression vector.  
The amplification of the DNA was made by PCR using a KOD Polymerase with an annealing 
temperature of 55ºC for 20s during 35 cycles.  
 
The ligation mixture was then transformed into DH5-α by heat shock and plated on LB+Kan. A 
PCR of the colonies obtained from the transformation was made to check which ones contain 
the recombinant plasmid. In this case, the oligonucleotides used in the PCR of the colonies 
were: SP6 and a reverse primer designed; and the conditions were: DFS-Taq DNA polymerase, 
annealing temperature of 37ºC for 20s and 35 cycles.  
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- Transformation of E.coli cells with plasmid DNA  
 
E.coli cells were defrosted on ice and DNA from the ligation reaction mix or pure plasmid DNA 
was added. Then, the E.coli were rested on ice for 30min, heat-shocked for 45s in a water bath 
at 42ºC and put on ice again for 5 min. Cells were resuspended with 1mL of medium and 
incubated at 37ºC for 1h at 250rpm. Finally, 100µL of culture were pipetted and plated onto 
plate with medium plus the required antibiotic and incubated at 37ºC for 24h.     
 
- Colony PCR 
 
Colony PCR was used to check which colonies from the transformation contain the vector with 
the inserted DNA fragment.  
Primers used in this PCR were: T7 as forward and a designed one as a reverse for the pET28a 
vector, and pGEX 5’ as a forward and a designed one as a reverse for the pGEX-4T-3. The 
conditions for the PCR used were: DFS-Taq DNA polymerase, annealing temperature of 55ºC 
for 20s and 35 cycles.  
 
- Expression of BC1 and BC2 genes  
 
To induce the expression of the proteins, BL21 cells were transformed with the plasmids 
previously obtained. Induction of protein expression was performed using 0.5mM of IPTG 
when the OD600 of the cultures was around 0.5. The induction was taken overnight at 20ºC 
shaking the cultures at 240rpm. The induced cells were harvested by centrifugation at 4º for 20 
min at 9.000 x g, and stored at -20ºC. 
18,19
 
 
- Purification of BC1 and BC2 from BL21 E.coli. 
 
To purify the recombinant BC1 and BC2, the E. coli cell pellets were resuspended in two bed 
volumes of lysis buffer (50 mM Tris pH 7.4, 150mM NaCl, 10% glycerol). Cell disruption was 
carried out by sonication at 4ºC for 2 min, and the lysate was centrifuged at 16.000 x g for 30 
min at 4ºC to remove the cell debris. Supernatant was retained for purification. Ni-NTA beads 
were previously equilibrated with 10mM imidazole in lysis buffer and then applied onto the 
supernatant cell-free extract.  
For 50 mL culture 200µL of Ni-NTA beads were used. The mixture was incubated at 4ºC 
rolling for 1h and washed first with 10 bed volumes of washing buffer (50mM Tris-HCl pH7.4, 
25mM imidazole, 150mM NaCl and 10% glycerol), and finally with 10 bed volumes of the 
same buffer including 300mM NaCl.  
 12  
 
The protein was eluted from beads by competition with imidazole following a gradient-step 
imidazole elution ranging from 50mM to 500mM at steps of 50mM in elution buffer (50mM 
Tris-HCl, 300mM NaCl and 10% glycerol). The mixture was incubated rolling at 4ºC for 15 
minutes with each different amount of imidazole. A sample of each step was taken for protein 
quantification. 
 
Enzyme fractions were analysed by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) using a 12% gel and visualized by staining with Coomassie blue.
20
 
 
- Protein quantification and determination of molecular mass 
 
Protein concentrations were determined by Bradford using the spectrophotometer at 595nm and 
using bovine serum albumin as protein standard. The molecular weight was determined by 
SDS-PAGE under denaturing conditions, using a prestained marker as a reference. 
21
 
 
- His-BC2 DNA cassettes for yeast transformation  
 
Taking pFA6-KanMX6-His-BC2 as a template, two PCRs were made in parallel to amplify the 
fragment of interest. The DNA cassette that is going to be inserted under the BC2 promoter was 
obtained using the oligonucleotides specially designed: His6-BC2-Kan-Fw, His6-BC2-Kan-Rv, 
while the one that is going to be inserted under the ENO2 promoter, was obtained using the 
oligonucleotides: His6-BC2-Kan-Fw-ENO2 and His6-BC2-Kan-Rv-ENO2 as primers. The 
amplification of the DNA was made by PCR using a KOD Polymerase with an annealing 
temperature of 60ºC for 10s during 35 cycles, and then the product was purified using the 
Illustra GFX PCR DNA and Gel Band Purification Kit. DNA concentration was measured with 
Nanodrop. 
22,23
 
 
- Yeast transformation 
 
For the transformation we first inoculate 5 mL YPD with a single yeast colony and incubate the 
culture at 30ºC overnight. The day after, an appropriate dilution of the pre-culture was done, in 
order to have 100mL of culture to a final OD=0.5 the third day. 50mL of the culture was 
centrifuged at 1300rpm for 3min at RT and the pellet was resuspended in 1mL of sterile H2O. 
Cells were spun at 2000rpm for 1min and the H2O was poured off. This wash step was repeated 
once. Next, the cells were washed once in TEL buffer (Tris EDTA Lithium acetate; 10mM Tris 
pH 7.7, 1mM EDTA, 100mM lithium acetate).  
 13  
 
225μl of TEL was added and the cells were resuspended. Transformation was made with 50μl 
of cells in a 1.5mL eppendorf tube. 5μl of pre-boiled salmon sperm DNA were added together 
with 10μl of PCR product. We added 350μl TEL/PEG (10mM Tris pH 7.7, 1mM EDTA, 
100mM lithium acetate, 40% PEG; polyethylene glycol) and mixed well the transformation 
mix. The mixture was incubated at 30ºC for 30min. Then, the tube was heat-shocked at 42ºC 
and incubated for 15min in the water bath. 
Cells were spun down for 1min at 2000rpm and the TEL/PEG was removed. Cells were 
resuspended in 1mL of YPD and incubated for 3h at 30ºC shaking. Cells were centrifuged at 
2000rpm for 1min and the YPD was removed completely. Finally, 50μl of sterile water was 
added to resuspend the cells and these were plated on YPD-G418 plates.     
 
- SDS-PAGE and Western blotting  
 
Colonies obtained from the transformation were put on a pre-culture. The OD of the pre-
cultures was measured and the corresponding volume of the culture was taken to have the same 
concentration of cells in each case. To check if the His tag was inserted in the genome, a 
Western Blot anti-His was made after breaking the cells in a mechanical way by series of 
vortex/boil. The first antibody used was Monoclonal anti-PolyHistidine, which is produced in 
mouse and the secondary was HRP-conjugated anti-mouse antibody. The membrane was 
incubated in Luminata Classico Western HRP substrate.  
 
- Purification of BC2 from S. cerevisiae  
 
Strains containing BC2 tagged with 6His at N-terminus (S441 and S442) were used to purify the 
BC2 protein. A culture of 1L volume of each strain was grown in YPD medium at 200rpm for 2 
days at 30ºC. Cell pellets were obtained from centrifugation at 4000rpm for 20min at 4ºC, the 
supernatant was eliminated and the pellets were resuspended with cold water. Pellet bottles were 
weighed before and after add the pellet to know how much it weighed. The pellet was obtained 
by centrifugation at 6000rpm for 15 min at 4º and stored at -80ºC. 
 
For purification of the recombinant BC, the pellet cells were resuspended with two bed volumes 
of lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 10% glicerol). Lysis was carried out by cell 
disrupter at RBAR 2.7 pressure at 4ºC and the lysate was centrifuged at 9000 x g for 30 min at 
4ºC to remove the cell debris. The resulting crude extract was retained for purification. Ni-NTA 
beads were previously equilibrated with 10mM imidazole in lysis buffer and then applied onto 
the supernatant cell-free extract.  
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For each 40 mL culture, 200µL of Ni-NTA beads were added. The next steps of protein 
purification (binding, washing and elution) follow the same protocol that the purification from 
E.coli. 
 
- Spectrophotometric determination of enzyme activity  
 
NAD-dependant enzymes are an important group of enzymes, which may be assayed rapidly by 
UV spectrophotometry. These enzymes use NAD
+
 as their coenzyme which is reduced to 
NADH during the reaction that takes place.
 24,25
 
 
Reduced NAD
+ 
(NADH) exhibits strong UV absorption at 340nm whilst oxidised form has 
virtually no absorption at this wavelength. Therefore if one starts with a mixture of substrate, 
NAD
+ 
and enzyme in buffer, the reaction proceeds until equilibrium is established. The reaction 
may be followed by measuring the increase in absorbance of the solutions at 340nm as NADH 
is formed.  
26
 
 
Specific activity of an enzymatic preparation is defined as the number of micromoles of formed 
product per minute per microgram of protein or per microgram of enzyme. 
27
 
 
The BC2 specific activity was determined by a spectrophotometer assay at 340nm during 1 min. 
Substrate was used at 1M concentration, Tris pH 7.4 50mM, EDTA 1mM was used as a buffer 
and  Nicotinamide Adenine Dinucleotide (NAD
+
) was used as a cofactor at 50mM.  
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5- Results  
 
In this project, we purified two different NAD dependent enzymes:  for the privacy policy of the 
project we cannot tell the name of the enzymes so we will call it BC1 and BC2 in this 
document. For BC1 protein, we had the corresponding gene already cloned into a pET28a 
vector, so we just induced and purified it. However, for the BC2 protein, we had to clone the 
gene first in the expression vector to, then, purify the protein. To express BC2, we decided to 
clone the gene in two different expression vectors: pET28a and pGEX-4T-3. We planned, also, 
to employ different model organisms and compare the differences in expression and efficiency 
of the protein between the different hosts. 
 
Cloning of BC2 gene in E.coli  
 
To be able to purify the BC2 protein from E.coli we had to subclone the BC2 DNA into an 
expression vector. We decided to subclone into two expression vectors because we want to 
purify it with two different techniques.   
With the pET28a vector, we wanted to express the BC2 protein fused to the 6*His tag that the 
vector contains, to purify it by Ni-NTA beads;  with the pGEX-4T-3 vector the intention was to 
express the BC2 protein fused to the GST tag given by the vector, to purify it later with 
glutathione sepharose.  
 
The BC2 gene was amplified from a BG1805 vector in which BC2 was previously cloned. In 
details, we first isolated the BG1805+BC2 vector, from our E. coli stock, using a miniprep kit as 
described in the materials and methods section. After the purification of the plasmid, we 
measure the concentration by using Nanodrop. 
 
Vector (BG1805+BC2)  420.2 ng/µL 
 
Next, the BC2 gene was amplified by PCR using BG1805+BC2 vector as a template. As we 
wanted to clone BC2 in two different plasmids, we used two oligonucleotide primers for each 
vector.   
 
EcoRI and XhoI sites were incorporated into the forward and reverse primers for cloning into 
the expression vectors (Fig.1). The samples were run in an agarose gel to confirm that the 
fragments were amplified (Fig.2).  
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The BC2 DNA fragment obtained with the PCR and the vectors were digested with restriction 
enzymes EcoRI and XhoI to create sticky ends in the DNA fragments and to open the 
expression vectors for the subsequent cloning, respectively. (Fig.3). Then, the product of the 
digestion was purified by column and run in the gel to check if the digestion worked properly 
(Fig.4). pGEX-4T-3 vector has a size of 4954bp and pET28a vector of 5369bp.  
 
 
.  
 
 
 
 
 
  
 
 
The BC2 DNA fragment was ligated into the vectors to give pET28a-BC2 and pGEX-4T-3-
BC2. The ligation mixtures were then transformed into DH5-α by heat shock and plated on 
LB+Kan and LB+Amp for pET28a and pGEX-4T-3 respectively. With the obtained colonies 
from the transformation, a colony PCR was made to check if the colony has the vector plus the 
insert, which means that the expected band should appear around 1242bp. The primers used for 
the PCR were the T7 primer and the reverse was specially designed.  
As no clear band was obtained in the gel of the colony PCR, we decided to extract the plasmid 
DNA from different colonies and check them by digestion, using EcoRI and XhoI as a 
restriction enzymes (Fig.5).  
BC2 
BC2 
(1044bp) 
Fig.1. Scheme of the amplification process for 
vector pET28a and pGEX-4T-3. 
Fig.2. Agarose gel showing the PCR product. 
BC2 
(1044bp) 
pET vector (4954bp) 
pGEX vector (5369bp) 
Fig.3. Agarose gel showing the 
vectors pET and pGEX not digested 
and digested. 
Fig.4. Agarose gel showing the vectors pET 
and pGEX and the inserts of BC2 digested. 
Fig.2.1. GenerRuler 1Kb 
Plus DNA Ladder. 
Thermo Scientific. 
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Unfortunately, after several ligations with pGEX-4T-3 vector, we did not manage to get 
colonies containing the vector + insert, so we will try it again in the future (Fig.6).  
 
 
 
 
 
 
 
 
 
 
 
 
We could see that in colonies 3, 4 and 6 two distinct bands appeared which means that the 
colony contains the vector (5369bp) plus the insert (1044bp). We obtained the plasmid DNA 
from these three colonies using the plasmid miniprep kit.  
To check that no mutations were inserted in the BC2 gene during the cloning, we decide to send 
them to sequence.  
 
First, a quantification of the plasmid DNA was made:  
Number of colony Quantity of DNA (ng/µL) 
Colony 3 (1) 61.6 
Colony 4 (2) 104.6 
Colony 6 (3) 83.2 
Table1. Concentration of the DNA measured with Nanodrop.    
Plasmid DNAs were sent to be sequenced to Centre for Research in Agricultural Genomics 
(CRAG) to make sure that no mutations occurred during the PCR.  
The three positive colonies were from the ligation with pET28a vector, so we asked for the 
corresponding plasmid DNA to be sequenced using the T7 promoter as a forward, and the T7 
terminal as a reverse primer.   
The sequences obtained from CRAG were compared to the data base reference sequence of BC2 
by alignment using the ApE program. (Images are not shown by confidential motifs). 
 
 
pET vector  pGEX vector  
Fig.5. Cloning in pET28a: agarose gel showing the product of 
the digestion of plasmid DNA from several 
Fig.6. Cloning in pGEX-4T-3: agarose gel showing the 
product of the digestion of plasmid DNA from several 
colonies. 
 18  
 
We can see how in some of the alignments there are “red points” that indicate a difference from 
the BC2 reference sequence, but in all the cases, the differences shown in the alignment of the 
forward or reverse is counteracted by the other alignment. As the red points just appear close to 
the primer alignment site, they are sequencing inaccuracies, and we can conclude that no 
mutations occurred. Of the three positive vectors, we chose two to continue with the 
experiment. These vectors receive the name of SJR 254 colony 1 and SJR 254 colony 2. 
 
Finally, the newly generated plasmids, SJR 254 colony 1 and SJR 
254 colony 2, was used to transform E. coli BL21 cells and, at the 
same time, we did the same with pET28a-BC1, which was already 
cloned (Fig.7). The colonies that were grown contain the pET28a 
vector in which BC2 or BC1 gene are inserted. These genes are 
under the control of the T7 promoter and are expressed as a protein 
fused to 6*His tag at the N-terminus. 
 
 
 
 
Heterologous expression of BC1 
 
As was previously explained, two different proteins were purified in this project: BC1 and BC2. 
At the beginning of the project, we started with the purification of BC1, for which the DNA was 
already cloned into pET28a.  
 
pET28a-BC1 vector was used to transform BL21 bacterial cells. From the resulted colonies, we 
picked up one to grow it in LB + Kanamycin liquid medium. Cell culture was induced with 
IPTG to express the plasmid, as described in material and methods section. After the induction, 
cell pellet was recovered and stored at -80ºC. Different volumes of protein extracts before and 
after induction were analysed by SDS-PAGE to check if there was expression of the BC1 
protein after induction (Fig.8). A protein of 50KDa, a size consistent with the predicted 
molecular mass for the BC1 protein, was identified in soluble extracts only from cells 
harbouring pET28a-BC1 and induced by IPTG. 
Fig.7. Scheme of the pET28a vector with 
the insertion of interest. His: histidine, 
DNA: BC1 or BC2. Restriction enzymes 
are shown. 
 19  
 
 
 
 
 
 
We can see how the expression of the protein is overexpress in the IPTG lanes, which means 
that the induction gone well. Our protein of interest is the stronger band, but we can see other 
bands that correspond to other proteins present in the cell.  
 
Purification of BC1  
 
To purify the recombinant BC1, cells has to be broken by sonication and protein extract has to 
be treated with different buffers for the binding, washing and elution process (see Matherials 
and Methods section).  
For the binding process, Ni-NTA beads were used. Ni-NTA Agarose is an affinity 
chromatography matrix for purifying recombinant proteins carrying a His tag. We used it in our 
experiment because the recombinant protein that was generated (pET28a-BC1) carries a His tag 
provided by pET28a vector. Histidine residues in the His tag bind to the vacant positions in the 
coordination sphere of the immobilized nickel ions with high specificity and affinity. Cleared 
cell lysates are loaded onto the matrix. His-tagged proteins are bound, and other proteins pass 
through the matrix in the washing steps.  
A sample of each wash was loaded in an SDS-PAGE to see it efficiency (Fig.10). 
Fig.8. Checking the expression of BC1 by SDS-PAGE stained with Coomasie Blue. Lane 4: 
Molecular standard marker. Lane 1-5: Different volumes of E.coli extract without IPTG. Lane 6-
10: Different volumes of E.coli extract after IPTG induction. An arrow indicates the protein of 
interest.   
 
Fig.9. PageRuler Prestained 
Protein Ladder. Thermo 
Scientific. 
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Fig10. SDS-PAGE showing the efficiency of washing. Lane 1: Molecular standard marker. Lane 2: Supernatant from 
the beads after binding and before washing. Lane 3-5:  Washes at 150mM NaCl. Lane 6-8: Washes at 300mM NaCl. 
Lane 10: Beads after washing.  
 
In the supernatant lane, we can see how all the proteins are in the supernatant excepting ours, 
which means that our protein was well attached to the beads.  
As well as the concentration of salt increased in the washing steps, we can see how the other 
protein bands were disappearing, which means that the wash process was efficient. 
After washing, His-tagged protein was eluted in buffer under native conditions. A gradient of 
imidazole was used because it acts by competition with histidine displacing the His-tag from 
nickel coordination, releasing the His-tagged protein.   
Enzyme fractions, 20µL for each lane, were analysed by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), using a 12% gel, and visualized by staining 
with Coomassie blue (Fig.11). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig11. Analysis of the eluted protein by SDS-PAGE and Coomassie blue staining. Lane1: Molecular standard 
marker. Lane 2-7: Samples of protein eluted at different concentrations of imidazole. Lane 9: Sample of the beads 
after the elution process.  
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We obtained the maximum elution using buffers with imidazole 150-200mM. The following 
elutions, with higher imidazole concentration, gave less protein amount because less quantity of 
the enzyme was still bounded to the beads. We can also see how, in the first lanes, apart from 
our protein of interest, there are other bands corresponding to other proteins, but in the 
following elutions these bands were disappearing and only BC1 is present. Finally, a sample of 
the beads was run and we can see a protein band, which indicates that the elution wasn’t 100% 
efficient.  
 
Protein quantification of BC1 
 
Protein concentrations were determined by Bradford method using bovine serum albumin as a 
standard protein; three different line patterns were used because the result given by the average 
of the three ones will be more accurate (Table2).  
 
 
y = 0,516x + 0,0394  R2= 0.999 
y = 0,5497x + 0,0061 R2 = 0.998 
y = 0,5639x - 0,0023 R2 = 0.999  
  
 
Table2: Protein concentrations of BC1 in E.coli. *value discarded 
 
Once obtained the concentrations, an estimation of the total quantity of purified protein was 
made, using the formulas written below (Equation (2)). First, we knew that we have 
approximately 300 µL of every elution, so we multiplied this quantity by the percentage 
obtained with the Bradford method. In a second step, we refer to the Coomassie stained samples 
(Fig. 11) to estimate which percentage of the Bradford quantification correspond to BC1 
protein.  
 
Sample 
 
OD 
595nm 
 
x = 
(y- 0,0394)/0,516 
 
8/dilution 
factor 
 
x = 
(y-0,0061)/0,5497 
 
8/dilution 
factor 
 
x = 
(y- 0,0023)/0,5639 
 
8/dilution 
factor 
Average  
Prot.Conc
(µg/µL) 
BC1 
100mM 0,144 0,203 0,102 0,251 0,126 0,260 0,130 0,12 
BC1 
150mM 0,168 0,250 0,125 0,295 0,148 0,303 0,151 0,14 
BC1 
200mM 0,154 0,221 0,111 0,268 0,134 0,276 0,138 0,13 
BC1 
250mM 0,046 0,012 0,006 0,072 0,036 0,085 0,042 0,03 
BC1 
500mM 0,020 -0,038 -0,019* 0,025 0,013 0,040 0,020 0,02 
Equation(1). Line patterns from bovine serum albumin.  
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For example, in the first lane, in which other unspecific bands are present, we considered that 
just 60% of the quantity of protein estimated by Bradford corresponds to BC1. We applied the 
same calculation to all the samples.  
 
Volume (µL) * Prot. Conc (µg/µL) = Total protein quantity (µg)  
Prot. Quantity (µg)* % specific prot. in SDS-PAGE = Prot. Quantity BC1 (µg) 
 
 
Elution 100mM 
0.3*0.12=0.036mg = 36µg 
36µg*0.6= 21.6µg 
 
Elution 150mM 
0.3*0.14=0.042mg = 42µg 
42µg*0.9= 37.8µg 
 
Elution 200mM 
0.3*0.13=0.039mg = 39µg 
39µg*0.95= 37.05µg 
 
These theoretical results, obtained starting from the base that we had 300µL for each elution, 
were put it in a table to compare with the real volume we had. The results gave us the total 
quantity of BC1 protein we could purify from 50 mL of bacterial culture.  
Sample 
Imidazole 
concentration 
Theoretical 
volume 
 (mL) 
Theoretical 
Protein 
quantity (µg) 
Real volume 
(mL) 
Real 
 Protein 
quantity 
(µg) 
Total 
(µg 
obtained 
from 50 mL) 
100mM 0,3 21,6 0,232 16,7 
 
150mM 0,3 37,8 0,232 29,23 
200mM 0,3 37,05 0,216 26,68 
250mM 0,3 9 0,248 7,44 
500mM 0,3 6 0,264 5,28 
 85,33 
Table3: Protein quantification of BC1 in E.coli 
 
We obtained a total of 85’33µg of BC1 protein from an initial culture of 50mL.We conclude 
that, expressing BC1 in a pET28a vector using BL21 bacterial cells is a quite efficient method 
to obtain a considerably pure BC1 protein. We had explained the process for the purification of 
BC1, and now we are going to see how this purification worked for BC2 protein.   
 
Equation(2). Formulas to calculate the quantity of a protein.  
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Heterologous expression of BC2 
 
Having generated the pET28-BC2 plasmid, we transformed this into BL21 as we explained in 
the cloning paragraph. The plasmids that were selected were the ones that come from the 
colonies number 1 and 2 (Table 1). With the colonies that result, a 5mL culture was grown in 
LB + Kan and after an overnight incubation, this culture was used to start a bigger 50 mL 
culture that was induced with IPTG when the OD600 was 0,762. The induced culture was 
grown overnight and the cell pellet was then recovered and stored at -80ºC until purification 
process.  
 
Different amounts of bacteria before and after induction were analysed by SDS-PAGE to check 
if there was expression of the BC2 protein after induction (Fig.12). A protein of 37KDa, the size 
expected, was identified in soluble extracts only from E.coli induced by IPTG.  
 
Fig12. Checking the expression of BC2 by SDS-PAGE. Lane 5: Molecular standard marker. Lane 1-4 E.coli extract 
without IPTG at different volumes and from different colonies. Lane 6-9: E.coli extract with IPTG at different 
volumes and from different colonies. An arrow indicates the protein of interest. 
 
We can see clearly how only BC2 protein is shown in a more intense band in the IPTG part of 
the gel, which indicates that the induction has gone well and that our protein is well expressed 
and the most abundant in the mixture of the sample.  
 
Purification of BC2  
 
To purify the recombinant BC2 protein, first of all E.coli cells need to be treated with sonication 
to break them and extract the proteins that are inside.  Then, the cell pellet was removed because 
contains the bacterial cell wall and the unbroken bacteria. Supernatant has to be treated with 
different buffers for the binding, washing, and elution process.  
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For the binding process, Ni-NTA beads are used, and the protein fused to the His tag provided 
by the pET vector are attached to nickel molecules on the beads. In the washing step, the buffer 
removes the other proteins that are not fixed so that mostly the recombinant protein that binds 
most strongly remains bound to the beads (Fig.13). 
 
Supernatant from the two different colonies after binding was loaded on 12% SDS-PAGE gel to 
visualize, by staining with Coomassie blue, if all the protein has been removed by the beads. 
 
Fig13. SDS-PAGE showing the samples of the washing steps for two colonies.  Lane 1: Molecular standard marker. Lane 2-3: 
Supernatant from the beads after binding and before washing. Lane 4-7: Washes at 150mM and 300mM NaCl concentration from 
colony 1. Lane 9-12: Washes at 150mM and 300mM NaCl concentration from colony 2. Lane 8 and 13: Beads after washing.  
 
We can see how in the first two lanes, the ones that belong to supernatants, there are a lot of 
bands indicating that there are a lot of proteins but ours, which indicates that all our protein is 
well bounded to the beads. In the lanes containing the washes; we can see how all the other 
proteins, which we are not interested in, are removed, which indicate that the beads now just 
contain our protein of interest. Lane 8 and 13 are a sample of beads and we can see a huge clear 
band which belongs to our protein of interest. All these results let us think that the wash step 
gone well and all the BC2 protein rest in the beads attached. Lanes 14 and 15 are the 
supernatant and the pellet after breaking the cells to see which fraction is insoluble. 
 
Next, the BC2 protein was eluted from the beads. This was done for the two colonies at 
different concentration of imidazole to see how the protein was eluted and checked that 
everything was removed from the beads (Fig.14).  
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Fig.14. Determination of the eluted protein by SDS-PAGE. Lane1: Molecular standard marker. Lane 2-7: Samples of 
the elution at different concentrations of imidazole for colony 1. Lane 9-14: Samples of the elution at different 
concentrations of imidazole for colony 1. Lane 8 and 15: Sample of the beads after elution.  
 
We can see how the stronger band has a size around 37KDa, which means that it is our 
protein of interest (BC). In addition, other bands appear in the gel but with a very low 
intensity indicating that our protein is well eluted and with a high level of purity. The 
stronger bands are shown when imidazole concentration is at 150-200mM indicating 
that the protein is well eluted at this range. However, protein is still attached to the 
beads as we can see in lanes 8 and 15, which indicates that the purification wasn’t 100% 
efficient.  
 
Protein quantification of BC2 from E.coli  
Protein concentrations of the colonies 1 and 2 were determined by Bradford method as was 
previously described for BC1 (Equation (1)). The results are described below (Table 4 and 5). 
 
Concentration of BC2 protein from colony 1 
Sample OD 
595nm 
x = 
(y- 0,0394)/0,516 
8/dilution 
factor 
x = 
(y-0,0061)/0,5497 
8/dilution 
factor 
x = 
(y- 0,0023)/0,5639 
8/dilution 
factor 
Average  
Prot.Conc(µg/µL) 
BC2 
50mM 0,051 0,022 0,011 0,082 0,041 0,095 0,047 0,03 
BC2 
100mM 0,336 0,575 0,287 0,600 0,300 0,600 0,300 0,30 
BC2 
150mM 0,507 0,906 0,906 0,911 0,911 0,903 0,903 0,91 
BC2 
200mM 0,238 0,385 1,540 0,422 1,687 0,426 1,705 1,64 
BC2 
250mM 0,101 0,119 0,478 0,173 0,691 0,183 0,733 0,63 
BC2 
500mM 0,152 0,218 0,218 0,265 0,265 0,274 0,274 0,25 
BC2 
500 (B)mM 0,059 0,038 0,019 0,096 0,048 0,109 0,054 0,04 
Table4: Protein concentrations of BC2 in E.coli for colony 1. 
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Concentration of BC2 protein from colony 2 
Sample OD 
595nm 
x = 
(y- 0,0394)/0,516 
8/dilution 
factor 
x = 
(y-0,0061)/0,5497 
8/dilution 
factor 
x = 
(y- 0,0023)/0,5639 
8/dilution 
factor 
Average  
Prot.Conc(µg/µL) 
BC2 
50mM 0,097 0,112 0,056 0,165 0,083 0,176 0,088 0,08 
BC2 
100mM 0,739 1,356 0,678 1,333 0,667 1,315 0,657 0,67 
BC2 
150mM 0,285 0,476 1,904 0,507 2,029 0,509 2,038 1,99 
BC2 
200mM 0,349 0,600 2,400 0,624 2,495 0,623 2,492 2,46 
BC2 
250mM 0,208 0,327 1,307 0,367 1,469 0,373 1,492 1,42 
BC2 
500mM 0,297 0,499 0,499 0,529 0,529 0,531 0,531 0,52 
BC2 
500 (B)mM 0,141 0,197 0,098 0,245 0,123 0,254 0,127 0,12 
Table5: Protein concentrations of BC2 in E.coli for colony 2.  
 
As we did for BC1 protein, an estimation of the quantity of purified protein was made knowing 
that we initially had a volume of 300µL and 3µL of these was loaded in the gel (Fig.14). The 
same formula was used in all these cases (Equation (2)). Results are shown in the following 
table (Table6).  
 
 
 
Table6: Protein quantification of each elution for BC2  
 
 
In the next table we can see the comparison between the theoretical result and the real one.   
 
 
 
 
 Protein quantity (µg) 
 Elution (mM) Colony 1 Colony 2 
 50 1.8 12 
100 72 161 
150 262 507 
200 479 665 
250 189 426 
500 75 156 
500 (B)  36 36 
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Protein quantification of colony 1  
Sample 
Imidazole 
concentration 
Theoretical 
volume 
 (mL) 
Theoretical 
Protein 
quantity (µg) 
Real volume 
(mL) 
Real 
 Protein 
quantity 
(µg) 
Total 
(µg in 50 
mL) 
50 mM 0,3 1,8 0,284 1,70 
 
100mM 0,3 72 0,284 68,16 
150mM 0,3 262 0,276 241,11 
200mM 0,3 479 0,298 476,03 
250mM 0,3 189 0,298 187,74 
500mM 0,3 75 0,284 71 
500mM (2)  0,3 36 0,284 34,08 
 1079,82 
Table7: Protein quantification of BC2 in E.coli for colony 1 
 
Protein quantification of colony 2 
Sample 
Imidazole 
concentration 
Theoretical 
volume 
 (mL) 
Theoretical 
Protein 
quantity (µg) 
Real volume 
(mL) 
Real 
 Protein 
quantity 
(µg) 
Total 
(µg in 50 
mL) 
50 mM 0,3 12 0,284 11,36 
 
100mM 0,3 161 0,284 152,22 
150mM 0,3 507 0,274 463,47 
200mM 0,3 665 0,298 659,77 
250mM 0,3 426 0,298 423,16 
500mM 0,3 156 0,284 147,68 
500mM (2)  0,3 36 0,284 34,08 
 1891,74 
Table8: Protein quantification of BC2 in E.coli for colony 2 
 
With these results, we can conclude that for 50mL of initial culture, we obtained 1079µg for the 
colony 1 and 1891µg for the colony 2, so we achieved more protein quantity of purified protein 
with the colony 2.   
 
Once we had the BC1 and the BC2 protein purified by E.coli, we decided to clone and express 
BC2 also in yeast to compare how the expression levels and to know from which organism we 
could obtain the most protein.  
 
Cloning and expression of BC2 gene in Saccharomyces Cerevisiae  
Once observed that BC2 protein is soluble, we decided to check how this protein was purified 
from yeast, concretely, for Saccharomyces cerevisiae.  
A PCR using the pET28a+BC2 (2) vector as a template was done to amplify the region of 
interest, which in this case was BC2 plus the His tag that the pET28a vector gives in the N-
terminus.  
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The primers used had the sequence of SalI and BglII restriction enzymes that would be used in 
the digestion for the subsequent cloning (Fig.15). An agarose gel was run to confirm that the 
fragment was amplified (Fig.16).  
 
 
 
 
 
 
 
 
The fragment obtained from the PCR (His tag + BC2) and the pFA6-KanMX6 vector were 
digested with restriction enzymes SalI and BglII to create sticky ends in the DNA fragments and 
to open the expression vector for the subsequent cloning. The product of the digestion was 
purified by column and ran in an agarose gel to check if the digestion works well (Fig.17). 
pFA6 vector has a size of 3938bp and the insert (His tag+BC2) has a size of 1177bp. 
The His tag + BC2 DNA fragment was ligated into the vector to give pFA6-His-BC2-Kan 
(Fig.18).  
  
 
 
 
 
  
 
 
 
We can see how the pFA6 vector was well digested because just one strong band appears in the 
gel in contrast with the not digested one.   
The ligation mixture was transformed into DH5-α and plated on LB+Kan. Around 100 colonies 
grew after being overnight at 37ºC.  
pET28a 
BC2 His 
BC2 (1177bp) 
Fig.15. Scheme of the pET28a vector with 
the oligonucleotides aligned.  
Fig.16. Agarose gel with the BC2 protein 
after amplification.  
Fig.18. Scheme of the pFA6 vector after 
ligation. His: histidine, DNA: BC2 
Restriction enzymes are shown.  
Vector pFA6 
His + BC2 
Fig.17. Samples of pFA6 vector were run in an 
agarose gel before (Lane1) and after (Lane 2 and 3) 
digestion. Insert of His+BC2 was also run.  
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From these colonies, we selected 10 and a colony PCR was made to check if any of those 
colonies contained the vector plus the insert, which means that the size of the vector should be 
increased by around 1177bp. If the colonies didn’t have the insert integrated, we expected to see 
a band of 200bp because this is the size between the two primer sites in the vector. The primers 
used for the PCR were SP6 as a forward and pFA6 control as a reverse.   
 
The product of the colony PCR was run on an agarose gel to see the size of the bands and 
determine if the colonies contain the vector with the insert inside (Fig.19). As no band was 
clearly seen, another 8 colonies were selected and the same protocol was applied (results are 
shown together) (Fig.20).  
 
  
 
 
 
  
 
 
            
 
 
No band showed that the vector contained the insert, but in two colonies we could see the 
control band of 200bp which indicated that the colony was transformed with the vector.  
However, we decided to make a second control growing a culture of the colonies, isolating 
plasmid DNA from these and measuring the concentration Nanodrop. The DNA was then 
digested with SalI and BglII because if the insert was present in the plasmid, two distinct bands 
should appear in the agarose gel (Table.9) (Fig 21; Fig 22).  
colonies 
 1    2    3    4     5 
 6    7    8    9   10 
11  12  13  14    
colonies 
  15   16  17   18   
Fig.19. Products of PCR from 10 
different colonies where run in the gel.  
Fig.20. Products of PCR from 8 
different colonies where run in the gel. 
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Table 9. Concentration of Plasmid DNA obtained from different colonies. 
 
 
 
 
 
 
 
  
 
In the first gel just one band was seen but the sizes vary between the colonies so we hypothesize 
that maybe the ones that are higher contain the insert and the problem was that the digestion 
didn’t work well.  Therefore, we decided to send the DNA from the first colony to be 
sequenced.  
In the second gel the same pattern was shown but, in this case, it seems that in colonies 11 and 
12 a second band appears at the size of insert (±1177) so, to confirm, we decided to digest again 
some samples but now using NdeI and NcoI as restriction enzymes (Fig.23). We chose these 
enzymes because they cut far from our insert. If no insert was present, we would see a band that 
confirmed that the digestion had gone well (Fig.24). 
- In case that the vector does not contain the insert: a band of 540 bp plus a band of 
3398bp. 
colonies 
 1    2     3     4     5 
 6     7      8     9    10 
Vector pFA6 
Vector pFA6 
colonies 
11  12  13  14  
15  16  17  18  
Vector pFA6 
Vector pFA6 
Insert His+BC2 
Fig.21. Products of digestion from the 10 
colonies selected are run in the agarose gel.  
Fig.22. Products of digestion from the 8 
colonies selected are run in the agarose gel.  
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- In case that the vector contain the insert: a band of 1717bp plus a band of 3938pb.  
 
In the agarose gel we run the pFA6 vector not digested and digested to see in which size the 
band for the vectors without the insert appears. Three different colonies were run also based on 
the gel from the Fig 22. For the negative control, colony 14 was chosen because the band was 
lower, and colonies 11 and 12 were tested to confirm if the colonies with the higher band 
contains the insert 
 
 
  
 
 
 
 
 
 
 
These results confirm that the colony 11
 
and 12 had the vector plus the insert, so we sent colony 
12 together with colony 1 from the gel of Fig 21 because there were just 2 differentiated bands 
while in colony 11 it seems that some contaminants appear. Both colonies were sequenced using 
SP6 as a forward primer, and the pFA6 control as a reverse primer.   
 
The sequences obtained from CRAG were compared with the reference sequence of BC2 by 
alignment using the ApE program. (Images are not shown by confidential motifs) 
We can see how in some of the alignments there are “red points” that indicate a difference from 
the BC2 reference sequence, but in all the cases, the differences shown in the alignment of the 
forward or reverse is counteracted by the other alignment. As the red points just appear close to 
the primer they are sequencing inaccuracies, so we assume that no mutations occurred.  
 
His-BC2 DNA cassettes for yeast transformation  
As there were no mutations in the sequences, we used these plasmids for the purification of BC2 
from yeast. First of all, a sample of wild type strain BY4741 was taken from our glycerol stock 
and scratched on YPD plate.  
For the purification process, we decided to prepare two different constructs that aligns with two 
different promoters for the His-BC2 and check which one works better in the protein 
pFA6 
Vector pFA6 
Insert His+BC2 
540bp band 
Fig.23. Scheme of the pFA6 vector with the 
insert on it. Restriction enzymes are shown.   Fig.24. Products of the digestion were run in the agarose gel.  
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expression. Both strategies used newly designed oligos: one for expression with the promoter of 
our protein (BC2) and the other with the promoter of Enolase (ENO2) (Fig.25).   
 
An amplification of the His tag + BC2 + Kan was made by PCR from the colony 1 already 
sequenced using oligos specially designed that align with the BC2 promoter or with the ENO2 
promoter (Fig 26; Fig 27). 
 
       pFA6 with promoter of BC2                                        pFA6 with promoter of ENO2 
 
 
 
 
 
 
 
 
 
 
The PCR product was purified by column and run on an agarose gel to make sure that the 
amplification worked well. The band expected was around 2459pb (Fig. 28).  
 
With the purified product, a yeast transformation 
was done with the culture prepared from the WT 
strain. The objective was to make a recombinant, 
changing the BC2 normal gene from the genome 
by the construct that we prepared that contains: 
His tag+BC2+Kan with the different promoters. 
The His-tag was used to purify the protein and 
the Kanamycin was useful for the selection of the 
colonies on YPD-G418 medium plates.  
Fig.25. Scheme of the two constructs prepared and the recombination process.  
pFA6 pFA6 
Fig.27. Scheme of the construct with the oligos 
containing the ENO2 promoter aligned.    
Fig.26. Scheme of the construct with the oligos 
containing the BC2 promoter aligned.    
His+BC2+Kan 
Fig.28. Product purified of the PCR from the two 
constructs was run on the agarose gel. 
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Checking the recombination 
 
The BY4741 cells that were transformed and grown on the plates produced colonies that contain 
the Kanamycin cassette, but to check if either contains the His-tagged protein, a western blot 
was made with some of the colonies (Fig.29).  For the ones that contain the ENO2 promoter, 8 
colonies were taken, and from the BC2 promoter were taken 18 colonies. 
 
Pre-cultures were made of the colonies, the OD was measured and the corresponding volume of 
the culture was taken to have the same amount of cells in each case. To check if the His tagged 
protein was inserted in the genome, a Western Blot with anti-His was made after breaking the 
cells in a mechanical way by series of vortex/boil. Protein fractions were analysed by SDS-
PAGE using a 10% gel. Monoclonal anti-PolyHistidine, antibody produced in mouse was used 
as primary antibody and HRP-conjugated anti-mouse antibody was used as secondary. After the 
incubation with the two antibodies and the corresponding washes, the PVDF membrane was 
incubated in Luminata Classico Western HRP substrate, a chemiluminescence detection reagent.  
 
 
 
 
 
 
 
 
 
On the film we can see how colony 5 and 8 from the ENO2 promoter and colony 3 and 10 from 
BC2 promoter contain the His-tagged BC2 in the genome. Colonies selected for the purification 
of BC2 were the number 8 from ENO2 promoter strain and the number 10 from BC2 promoter 
strain. 
 
Purification of BC2 from S. cerevisiae 
Two cultures of 1L YPD medium were prepared for growth of the yeast strains, one for the 
ENO2 promoter and the other for the BC2 promoter. After growing the cultures for two days, 
these were centrifuged and the cell pellet was weighted.  
 
Fig.29. Cell extract from different colonies was analysed by SDS-PAGE analysis, following the histidine by 
immunoblotting against His.  
1    2     3    4   5    6   7   8      1    2   3    4    5   
ENO2 promoter BC2 promoter 
6   7   8   9   10   11  12  13  14  15  16  17 18  
BC2 promoter 
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Pellet weight from BC2 with BC2 promoter  15.65g 
Pellet weight from BC2 with ENO2 promoter  13.5g 
 
The purification process used was the same as described for E.coli on “Purification from E.coli” 
section but with the difference that for breaking the cells, a cell disrupter was used. Total 
volume of the protein extract was 50mL. In the last step of the purification, elution was made 
and the samples at different imidazole concentrations were collected in a total volume of 200µL 
of elution buffer. 
 
The OD of these samples was taken to see how much protein we had and to check if the elution 
process was working well. To continue, a sample of the supernatant was run on SDS-PAGE gel 
to observe how many proteins we had in our samples and if the BC2 protein was also present 
(Fig.30). BC2 has a size of 37 KDa, so we expected to see a bigger band in this zone because 
this would indicate that our protein is the majority and the elution step worked.   
 
 
 
 
 
 
 
 
 
 
In this gel we can see how we had the protein of interest in the sample. The maximum protein 
eluted was when the concentration of imidazole was at 100-200mM in both cases.  
We can also see other bands that correspond to other proteins that were eluted together with our 
sample, and are also in the latest steps of the elution, so we can think that maybe are other 
proteins presents that have affinity with the beads and the purity of the sample was not as good 
as in the E.coli.  
 
The 100mM elution samples were used to make a western blot with anti-his with the intention 
to check if the His tag was still remaining in the genome.  
BC2 
BC2 promoter ENO2 promoter 
Fig.30. Determination of the eluted protein by SDS-PAGE. Lane1: Molecular standard marker. Lane 2-7: Samples of the 
elution at different concentrations of imidazole for BC2 promoter. Lane 9-14: Samples of the elution at different 
concentrations of imidazole for ENO2 promoter. Lane 8 and 15: Sample of the beads after elution. 
 35  
 
The same antibodies that were used for the previous western blot were used now, but membrane 
was incubated with the Amersham ECL Prime Western Blotting Detection Reagent (Fig.31).   
 
 
 
 
 
 
 
 
 
 
 
 
The Histidine control (control pET-BC2) was obtained from the elution sample from the colony 
2 of E.coli purification at 100mM of imidazole. In the gel are run the supernatants before and 
after binding to check if the protein was well attached to the beads. Finally, an elution sample at 
100mM obtained from this purification was added.  
We cans see how in the long exposure film, a band appears in all the lanes. However, no band or 
very little band was expected in the SN after binding, and in the BC2 promoter region we can 
see how this band is equal to the supernatant before binding meaning that probably the amount 
of beads was not sufficient to remove all protein. Most importantly, we can see a band in the 
elution lane, so it means that we have purified protein.  
We have obtained more protein from the ENO2 promoter strain than for the BC2 strain.  
Protein quantification and determination of molecular mass 
As we mentioned previously, colonies 8 and 10 were used to purify BC2 protein containing the 
ENO2 promoter and the BC2 promoter respectively.   
Using the same method as previously was described for E.coli; we obtained the protein 
concentration for BC2 in Saccharomyces cerevisiae (Equation (1)) (Table 10 and 11). 
 
 
 
 
BC2 promoter ENO2 promoter 
His 
B) 
Fig.31. Determination of the His tag in a SDS-PAGE analysis, following the histidine by immunoblotting against His.  
SDS-PAGE gel was made at 10% of acrylamide. A) Time of exposure 5min. B) Time of exposure ON.  
BC2 promoter ENO2 promoter 
His 
A) 
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Concentration of BC2 protein from colony 8 (ENO2 promoter) 
Sample OD 
595nm 
x = 
(y- 0,0394)/0,516 
8/dilution 
factor 
x = 
(y-0,0061)/0,5497 
8/dilution 
factor 
x = 
(y- 0,0023)/0,5639 
8/dilution 
factor 
Average  
Prot.Conc(µg/µL) 
PromoENO2 
50mM 0,257 0,422 0,422 0,456 0,456 0,460 0,460 0,45 
PromoENO2 
100mM 0,295 0,495 0,495 0,526 0,526 0,527 0,527 0,52 
PromoENO2 
150mM 0,279 0,464 0,464 0,496 0,496 0,499 0,499 0,49 
PromoENO2 
200mM 0,345 0,592 0,296 0,617 0,308 0,616 0,308 0,30 
PromoENO2 
250mM 0,185 0,282 0,141 0,325 0,163 0,332 0,166 0,16 
PromoENO2 
500mM 0,108 0,133 0,066 0,185 0,093 0,196 0,098 0,09 
PromoENO2 
500 (B)mM 0,059 0,038 0,019 0,096 0,048 0,109 0,054 0,04 
Table10: Protein concentrations of BC2 in S. cerevisiae for colony 8. 
 
Concentration of BC2 protein from colony 10 (BC2 promoter) 
Sample OD 
595nm 
x = 
(y- 0,0394)/0,516 
8/dilution 
factor 
x = 
(y-0,0061)/0,5497 
8/dilution 
factor 
x = 
(y- 0,0023)/0,5639 
8/dilution 
factor 
Average  
Prot.Conc(µg/µL) 
PromoBC2 
50mM 0,124 0,164 0,164 0,214 0,214 0,224 0,224 0,20 
PromoBC2 
100mM 0,279 0,464 0,464 0,496 0,496 0,499 0,499 0,49 
PromoBC2 
150mM 0,231 0,371 0,371 0,409 0,409 0,414 0,414 0,40 
PromoBC2 
200mM 0,339 0,581 0,290 0,606 0,303 0,605 0,303 0,30 
PromoBC2 
250mM 0,173 0,259 0,129 0,304 0,152 0,311 0,155 0,15 
PromoBC2 
500mM 0,126 0,168 0,084 0,218 0,109 0,228 0,114 0,10 
PromoBC2 
500 (B)mM 0,077 0,073 0,036 0,129 0,064 0,141 0,070 0,06 
Table11: Protein concentrations of BC2 in S. cerevisiae for colony 10. 
 
An estimation of the quantity of purified protein was made knowing that we initially had a 
volume of 200µL and 3µL of these was loaded in the gel (Fig.30) (Table 12).  
The same formula was used in all these cases (Equation (2)). 
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Table12: Protein quantification of each elution for BC2  
 
In the next table we can see the comparison between the theoretical result and the real one 
(Table 13 and 14).  
 
Protein quantification of colony 8 (ENO2 promoter) 
Sample 
Imidazole 
concentration 
Theoretical 
volume 
 (mL) 
Theoretical 
Protein 
quantity (µg) 
Real volume 
(mL) 
Real 
 Protein 
quantity 
(µg) 
Total 
(µg in 50 
mL) 
50 mM 0,2 45 0,192 43,20 
 
100mM 0,2 73 0,192 69,89 
150mM 0,2 59 0,192 56,45 
200mM 0,2 45 0,184 41,40 
250mM 0,2 26 0,184 23,55 
500mM 0,2 16 0,184 14,90 
500mM (2)  0,2 8 0,184 7,36 
 256,75 
Table13: Protein quantification of BC2 in S. cerevisiae for colony 8 
 
Protein quantification of colony 10 (BC2 promoter) 
Sample 
Imidazole 
concentration 
Theoretical 
volume 
 (mL) 
Theoretical 
Protein 
quantity (µg) 
Real volume 
(mL) 
Real 
 Protein 
quantity 
(µg) 
Total 
(µg in 50 
mL) 
50 mM 0,2 12 0,192 11,52 
 
100mM 0,2 49 0,192 47,04 
150mM 0,2 48 0,192 46,08 
200mM 0,2 42 0,184 38,64 
250mM 0,2 24 0,184 22,08 
500mM 0,2 18 0,184 16,56 
500mM (2)  0,2 12 0,184 11,04 
 192,96 
Table14: Protein quantification of BC2 in S. cerevisiae for colony 10 
 
 Colony 8 Colony 10 
 Elution (mM) Protein quantity (µg) 
 50 45 12 
100 73 49 
150 
59 48 
200 
45 42 
250 
26 24 
500 
16 18 
500 (B)  
8 12 
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With these results, we can conclude that for 50mL of initial culture, we obtained 257µg of BC2 
protein for the strain with ENO2 promoter and 193µg for the strain with BC2 promoter, so we 
obtained more purified protein using the ENO2 promoter.   
These two new strains were called: S441 for the BC2 promoter and S442 for the ENO2 
promoter.   
 
Spectrophotometric determination of enzyme activity  
 
After the isolation and purification of the protein, an assay to determine the amount and purity 
of the enzyme and to assess its kinetic characteristics was performed. The measure of the 
conversion of substrate to product in a short period of time was done by spectrophotometry.  
 
The activity assay is based on the detection of the absorbance difference between NADH and 
NAD
+
. NADH absorbs at 340nm, while NAD
+
 doesn’t absorb at this wavelength. The enzyme 
activity in the samples will be detected as an increase in the absorbance at 340nm, due to the 
reaction in which NAD
+
 is converted to its reduced form, NADH.  
 
The BC2 specific activity was determined by a spectrophotometer assay at 340nm during 1 min. 
Substrate used was at1M concentration, Tris pH 7.4 50mM, EDTA 1mM was used as a buffer 
and  Nicotinamida Adenine dinucleotide (NAD
+
) was used as a cofactor at 50mM. The protein 
tested was the BC2 purified from E.coli and the one obtained from yeast with ENO2 promoter.  
 
1.25mM NAD+  
25mM substrate  
X µg enzyme (see table 17- µg protein) 
XµL buffer up to 800µL 
 
Absorbance measurements were taken for different elutions obtained from the purifications 
described before (Equation (3). The measure of the concentration was calculated taking into 
account the difference of the absorbance in this time lapse (Table 15). 
 
 
Δ Absorbance = Absf  - Absi 
C = Δ Abs/e*l (M-1); (e= 6,22·103cm-1 M-1, l=1cm-1)  
 
Equation(3). Formula of the increment of absorbance (up) and Lambert-Beer formula (down) 
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Table 15. Measure of the concentration of the protein by the increasing of absorbance.  
 
Specific activity of an enzymatic preparation is defined as the number of micromoles of formed 
product per minute per microgram of protein or per microgram of enzyme (Equation (4)).  
Specific Activity = (µMols NADH/min)/µg enzyme  
 
Equation(4). Specific activity formula 
 
This result will tell us how efficient is our protein, in other words, how much substrate can 
transform to product in a short period of time.  
We decided to calculate the activity in reference to seconds, hours and days to understand the 
results in a clearly way (Table 17).   
  Table 17. Measure of the specific activity of the protein.  
 
 E. coli S. cerevisiae 
Elution sample Δ Absorbance c= ΔAbs/(e*L) (M
-1
) Δ Absorbance c= ΔAbs/(e*L) (M
-1
) 
50 0,2081 3,35E-05 0,2467 3,97E-05 
100 0,1942 3,12E-05 0,2418 3,89E-05 
150 0,2072 3,33E-05 0,2546 4,09E-05 
200 0,2444 3,93E-05 0,2312 3,72E-05 
250 0,101 1,62E-05 0,1934 3,11E-05 
500 0,011 1,77E-06 0,0935 1,50E-05 
500 (B) 0,011 1,77E-06 0,039 6,27E-06 
Specific Activity of enzyme 
E. coli 
 
Sample 
 
c= Δabs/(e*L) (M-1) 
 
µg 
protein 
 
Specific Act.  
(µMols/s)/µg) 
 
Specific Act. 
(µMols/h)/µg  
 
Specific Act. 
(µMols/d)/µg 
 
50 3,35E-05 0,4 1,39 5018,49 120443,73 
100 3,12E-05 3,35 0,16 559,20 13420,74 
150 3,33E-05 9,95 0,06 200,88 4821,02 
200 3,93E-05 12,3 0,05 191,67 4600,11 
250 1,62E-05 7,1 0,04 137,22 3293,33 
500 1,77E-06 2,6 0,01 40,81 979,47 
500 (B) 1,77E-06 0,6 0,05 176,85 4244,37 
S.Cerevisiae 
 
Sample c= Δabs/(e*L) (M-1) 
 
µg 
protein 
 
Specific Act. 
(µMols/s)/µg 
 
Specific Act. 
(µMols/h)/µg  
 
Specific Act. 
(µMols/d)/µg 
 
50 3,89E-05 2,25 0,29 1057,66 25383,92 
100 4,09E-05 2,6 0,25 897,11 21530,55 
150 3,72E-05 2,45 0,28 1002,43 24058,27 
200 3,11E-05 1,5 0,41 1486,82 35683,60 
250 1,50E-05 0,8 0,65 2331,99 55967,85 
500 6,27E-06 0,45 0,56 2004,29 48102,89 
500 (B) 3,97E-05 0,2 0,52 1881,03 45144,69 
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In this table we can see how E.coli and S. cerevisiae had obtained more or less the same 
concentration of protein in total, but S. cerevisiae is more efficient than E.coli because a higher 
specific activity was obtained having less quantity of purified protein, which means that the 
protein is more efficient when is grown in this model organism.    
 
6- Discussion  
In this project, the main goal was to find the best purification method to obtain pure protein with 
a high yield that can be used later in some biotechnology applications.  
To achieve this goal, we first purified BC1 protein from E.coli to test the purification conditions 
for the selected method because the plasmid was already available in the laboratory. As an 
expression system, we used pET28a plasmid in which an N-terminal 6*His fusion protein of 
BC1 was generated that can be induced by IPTG so that the protein can be purified with Ni-
beads.  
From the results obtained, we can say that E.coli is a good host and it allows the expression of 
the protein of interest to obtain a high amount of it. Moreover, the purified product was very 
pure, so a His-tag will be a good option to use for the BC2 protein.  
 
Nevertheless, the optimal purification system is different for every protein, that’s why we also 
wanted to test how the GST purification will work. Sometimes GST tag works better but is 
much bigger than His-tag and is sometimes needed to get a soluble protein. However, in that 
case, the GST tag needs to be cleaved off subsequently.  This is why we originally designed an 
expression vector containing the His-tag, but another one with the GST tag. Unfortunately, 
cloning with pGEX-4T-3 vector which contains the GST tag did not work, so we decided to 
continue just with the His-tagged protein that was expressed by the pET28a vector.  
We studied the expression from two different colonies and the results obtained were more than 
the expected ones, because we obtained up to 20 times more purified protein than for BC1 and 
with a high purity.  
 
At this point, we decided to express this protein also in yeast because it is already expressed in 
its genome, so we used S. cerevisiae as a host organism. In addition, we wanted to induce its 
expression by two different promoters, so we designed two mechanism of expression; one using 
the promoter belonging to our protein, and the other was from the enolase gen (ENO2). We 
chose ENO2 because it is one of the most studied and used promoters in yeast and its expression 
can be regulated by non-fermentable carbon sources or induced by glucose, that’s why we 
hypothesize that with this one we could obtain more protein. The purification was done, as in 
E.coli, using the His-tag method. 
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Comparing the expression of the protein with the two promoters used, we could see how, as we 
expected, the ENO2 promoter works more efficiently than the BC2 promoter and that’s why we 
have obtained more purified protein from the strain expressed by ENO2 promoter. However, the 
total quantity of the protein collected by S. cerevisiae was lower than that obtained from a 
similar amount of culture volume by E.coli.  
 
Finally, an enzymatic assay was done comparing the BC2 product of the E.coli with the S. 
cerevisiae expressed from the ENO2 promoter.  For the last one we observed higher activity, 
which means that a particular amount of BC2 protein purified from yeast converts more 
substrate into product in the same amount of time than a similar amount of BC2 purified from 
E.coli as we can see in the activity table, where from sample 500(B), for example, more quantity 
of protein was added from E.coli sample but more activity was obtained from S. cerevisiae. 
To summarize, if we compare the two host organisms used in this experiment, we can see how 
E. coli is a better system for producing a lot of protein than S. cerevisiae because it grows faster 
and produce protein more quickly. However, the activity of BC2 obtained from yeast was 
higher than the one obtained from bacteria. 
In our case, we will continue using yeast for the expression of BC2 protein, using ENO2 
promoter for our production experiments but testing other conditions as well such as test with 
different glucose amounts in the medium.  
 
 
7- Conclusions  
After studying the results obtained in this project, we can say that the best expression system to 
obtain a purified protein is Escherichia coli because you can obtain the same product multiplied 
per 6.  
If we focus on yeast, the best expression mechanism is use the glucose induction by ENO2 
promoter because is a very stronger promoter.  
 
 
This project is a part of a biggest project in which we are working in, and it helped us to develop 
the best method for a stable overexpression of a protein in yeast, and we will use it later for new 
purifications with other proteins. Looking forward, we also want to develop another method to 
compare it with these ones using more glucose in the induction of the protein expression in 
yeast with ENO2 promoter.   
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